Skip to main content
SpringerLink
Log in

The Effects of the Internet on Pharmaceutical Consumers and Providers

  • Review Article
  • Published:
Disease Management & Health Outcomes

Abstract

The Internet has changed healthcare practice and has just begun to influence pharmaceutical consumers and providers. The Internet firstly affects the pharmaceutical consumer through the five main functions it offers to all consumers of care. These functions are: (i) to provide and distribute information; (ii) to support informed decision making; (iii) to promote health; (iv) to provide a means for information exchange and support (the community concept) and; (v) to increase self care and manage the demand for health services, thus, lowering direct medical costs. Secondly, the Internet influences the pharmaceutical consumer by enhancing the move to consumer empowerment. Thirdly, it offers increased self-care capabilities to consumers through pharmaceutical information gathering and pharmaceutical products and services purchasing using Internet pharmacies. Finally, the Internet affects the pharmaceutical consumer by enhancing efficiency in the medical management of patients.

It does this by providing the means for telemedicine and telepharmacy, by changing the healthcare professional-patient relationship, and by providing a tool for registering adverse drug events. Disease management benefits include: (i) access to care for remotely located consumers; (ii) the possibility of peer consultation and of access to diagnostic and therapeutic Internet information for healthcare providers; and (iii) continuity of care via virtual community networks, integrated health systems, interconnected, real-time, virtual healthcare teams, and virtual unified electronic health records. The Internet’s effect of increasing knowledge of illicit and unregulated drugs, which may change drug use behavior and drug culture, though, makes the medical management of patients less efficient.

The effects of the Internet on the pharmaceutical provider firstly relate to technological and managerial changes. The Internet, secondly, induces changes in the provision of pharmaceutical care by offering the means for telemedicine, telepharmacy, and e-commerce, for advertising, promotion, and communication with consumers, and for supporting drug safety and pharmacovigilance.

The Internet’s positive influence on pharmaceutical consumers and providers, however, mainly will depend on whether proper solutions can be found for the privacy/security and confidentiality problems existing in pharmaceutical information gathering and pharmaceutical products and services purchasing. Special focus should be placed on ensuring the privacy of consumer information and on the secure transmission of financial information. The best defenses will be adequate, national, international, and global laws and regulations which ensure privacy/security and confidentiality on a global level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gentile JA. Databases, websites, and the Internet. Oncology (Huntingt) 1998 Nov; 12(11A): 356–9.

    Google Scholar 

  2. Navarro RP. Internet pharmacies: opportunities and challenges. Manag Care Interface 1999 Jun; 12(6): 64, 66–7.

    Google Scholar 

  3. Dupuits FMHM. The role of community health information networks in disease management. Dis Manage Health Outcomes 2000 Oct; 8(4): 185–95.

    Article  Google Scholar 

  4. D’Emanuele A. Are you being pushed? PharmWeb: news from the Internet [online] 1997 Nov/Dec; 11(6). Available from URL: http://www.pharmweb.net/pwmirror/pwf/pharmwebf38.html [Accessed 2002 Oct 3].

  5. D’Emanuele A. Interactivity. PharmWeb: news from the Internet 1997 [online] Jul/Aug; 11(4). Available from URL: http://www.pharmweb.net/pwmirror/pwf/pharmwebf36.html [Accessed 2002 Oct 3].

  6. Angaran DM. Telemedicine and telepharmacy: current status and future implications. Am J Health Syst Pharm 1999 Jul 15; 56: 1405–26.

    PubMed  CAS  Google Scholar 

  7. Frank SR. Digital health care: the convergence of health care and the Internet. J Ambulatory Care Manage 2000 Apr; 23(2): 8–17.

    PubMed  CAS  Google Scholar 

  8. Dupuits FMHM. Diagnostic decision support for general practitioners [dissertation]. Maastricht: Maastricht University, 1997.

    Google Scholar 

  9. Breeuwer M, Wadley JP, De Bliek HL, et al. The EASI project: improving the effectiveness and quality of image-guided surgery. IEEE Trans Inf Technol Biomed 1998 Sep; 2(3): 156–68.

    Article  PubMed  CAS  Google Scholar 

  10. Thornton PD, Simon S, Mathew TH. Towards safer drug prescribing, dispensing and administration in hospitals. J Qual Clin Pract 1999 Mar; 19(1): 41–5.

    Article  PubMed  CAS  Google Scholar 

  11. Bolton P, Douglas K, Booth B, et al. A relationship between computerisation and quality in general practice. Aust Fam Physician 1999 Sep; 28(9): 962–5.

    PubMed  CAS  Google Scholar 

  12. Gerlach K, Kaeding A, Kottmair S, et al. The implementation of a quality-net as a part of the European project DIABCARE Q-Net. IEEE Trans Inf Technol Biomed 1998 Jun; 2(2): 98–104.

    Article  PubMed  CAS  Google Scholar 

  13. Dissanayake VH, Jayasekara RW. Pattern of use of medical information made available via an Internet website. Ceylon Med J 1999 Mar; 44(1): 14–7.

    PubMed  CAS  Google Scholar 

  14. Zura A, Smith MP. Medical resources for the anesthesiologist on the Internet. Reg Anesth Pain Med 2000 Jan–Feb; 25(1): 99–102.

    PubMed  CAS  Google Scholar 

  15. Weiss SR, Cooke CE, Bradley LR, et al. Pharmacist’s guide to pregnancy registry studies. J Am Pharm Assoc 1999 Nov/Dec; 39(6): 830–4.

    CAS  Google Scholar 

  16. Jones D. Web alert: molecular vaccines for disease prevention and therapy. Curr Opin Mol Ther 2001; 3(1): 11–2.

    PubMed  CAS  Google Scholar 

  17. Sica JM. Managing prescription drug costs. Employee Benefits J 2001 Mar; 26(1): 35–40.

    CAS  Google Scholar 

  18. Miller TE, Reents S. The health care industry in transition: the online mandate to change [online]. Internet Strategies Group Cyber Dialogue Inc; 1998. Available from URL: http://www.cyberdialogue.com/pdfs/wp/wp-cch-1999-transition.pdf [Accessed 2002 Oct 10].

  19. Peterson AM. A survey of selected Internet pharmacies in the United States. J Am Pharm Assoc 2001 Mar/Apr; 41(2): 205–12.

    CAS  Google Scholar 

  20. Ukens C. Internet pharmacies. Drug Topics 1999 May; 17: 63–70.

    Google Scholar 

  21. Latner AW. Pharmacists on the Internet: how to attract customers. Pharm Times 1998; 64: 78.

    Google Scholar 

  22. Landis NT. Virtual pharmacies boast easy access, privacy safeguards. Am J Health Syst Pharm 1999; 56: 1174, 1177–9.

    Google Scholar 

  23. Field MJ, editor. Telemedicine: a guide to assessing telecommunications in health care. Institute of Medicine, Washington (DC): National Academy Press, 1996.

    Google Scholar 

  24. National Association of Boards of Pharmacy. VIPPSTM information and verification site. Available from URL: http://www.nabp.net/vipps/intro.asp [Accessed 2002 Oct 3].

  25. National Association of Boards of Pharmacy. VIPPSTM Disclaimer. Available from URL: http://www.nabp.net/vipps/vippsDisclaimer.asp [Accessed 2002 Oct 3].

  26. Marwick C. Several groups attempting regulation of Internet Rx. JAMA 1999; 281: 975–6.

    Article  PubMed  CAS  Google Scholar 

  27. Paulsen M. New NABP program combines criteria, inspections to certify online pharmacy quality. J Am Pharm Assoc 1999; 38: 870.

    Google Scholar 

  28. National Association of Boards of Pharmacy Model Pharmacy Act. Definitions, section 1 Gg., 1998. Available from URL: http://www.nabp.net [Accessed 2002 Oct 3].

  29. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: meta-analysis of prospective studies. JAMA 1998; 279: 1200–5.

    Article  PubMed  CAS  Google Scholar 

  30. Ozdemir V, Shear NH, Kalow W. What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects? Drug Saf 2001; 24(2): 75–85.

    Article  PubMed  CAS  Google Scholar 

  31. Cobert B, Silvey J. The Internet and drug safety: what are the implications for pharmacovigilance? Drug Saf 1999 Feb; 20(2): 95–107.

    Article  PubMed  CAS  Google Scholar 

  32. Bogenschutz MP. Drug information libraries on the Internet. J Psychoactive Drugs 2000 Sep; 32(3): 249–58.

    Article  PubMed  CAS  Google Scholar 

  33. Halpern JH, Pope HG. Hallucinogens on the Internet: a vast new source of underground drug information. Am J Psychiatry 2001 Mar; 158(3): 481–3.

    Article  PubMed  CAS  Google Scholar 

  34. Graeme KA. New drugs of abuse. Emerg Med Clin North Am 2000 Nov; 18(4): 625–36.

    Article  PubMed  CAS  Google Scholar 

  35. Shannon M, Quang LS. Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature. Pediatr Emerg Care 2000; 16(6): 435–40.

    Article  PubMed  CAS  Google Scholar 

  36. Agar M, Bourgois P, French J, et al. Buprenorphine: “field trials” of a new drug. Qual Health Res 2001 Jan; 11(1): 69–84.

    Article  PubMed  CAS  Google Scholar 

  37. Dayton CS, Ferguson JS, Hornick DB, et al. Evaluation of an Internet-based decision-support system for applying the ATS/CDC guidelines for tuberculosis preventive therapy. Med Decis Making 2000 Jan–Mar; 20(1): 1–6.

    Article  PubMed  CAS  Google Scholar 

  38. Cauchon M, Leduc Y. Trouver la bonne information au bon moment: Partie 1: Médication, livres de référence, guides de pratique. Can Fam Physician/Le Médicin de famille canadien 2001 Feb; 47: 348–9.

    Google Scholar 

  39. Knapp KK, Blalock SJ, O’Malley CH. ASHP survey of ambulatory care responsibilities of pharmacists in managed care and integrated health systems, 1999. Am J Health Syst Pharm 1999 Dec 1; 56: 2431–43.

    PubMed  CAS  Google Scholar 

  40. Mehl B, Santell JP. Projecting future drug expenditures, 2000. Am J Health Syst Pharm 2000 Jan 15; 57: 129–38.

    PubMed  CAS  Google Scholar 

  41. Hensley S. GPOs under pressure to deliver: purchasing volume climbs, but Internet firms and independents are challenging the large groups. Mod Healthc 1999 Sep 20; 29(38): 38–47.

    Google Scholar 

  42. Salazar A, Howells J. Creating knowledge structures in the pharmaceutical industry: the increasing significance of virtual organisation. World Hosp Health Serv 2000; 36(2): 6–10.

    PubMed  CAS  Google Scholar 

  43. Gambardella A. Science and innovation: the US pharmaceutical industry during the 1980s. Cambridge: Cambridge University Press, 1995.

    Book  Google Scholar 

  44. Randle K, Rainnie A. Creativity and control in a pharmaceutical R&D company: the case of Glaxo Research and Development. University of Hertfordshire Business School, 1994. Working paper series no.: 7.

  45. Delia Valle F, Gambardella A. Biological revolution and strategies for innovation in pharmaceutical companies. R&D Manage 1993; 23 (4).

  46. Rau R. Outline for a nationwide co-operation in planning and performing multicenter studies in rheumatology [in German]. Ztschr Rheumatol 2000; 59(1): 50–2.

    Article  CAS  Google Scholar 

  47. Mann HJ. Pharmacy technology of the ICU: today and tomorrow. Crit Care Clin 2000 Oct; 16(4): 641–58.

    Article  PubMed  CAS  Google Scholar 

  48. Malone T, Laubacher R. The dawn of the e-lance economy: are big companies becoming obsolete? Harv Bus Rev 1998 Sep–Oct: 145–52.

  49. Timmers P. Electronic commerce: strategies and models for business-to-business trading. Wiley Series in Information Systems. Chichester: Wiley & Sons, 1999.

    Google Scholar 

  50. Iansiti M, Maccormack A. Developing products on Internet time. Harv Bus Rev 1997 Sep–Oct: 108–24.

  51. Prahalad C, Hamel G. The core competence of the corporation. Harv Bus Rev 1990; 68: 79–91.

    Google Scholar 

  52. Chiesa V, Manzini R. Managing virtual R&D organizations: lessons from the pharmaceutical industry. Int J Technol Manage 1997; 13: 471–85.

    Article  Google Scholar 

  53. Staropoli C. Cooperation in R&D in the pharmaceutical industry: the network as an organizational innovation governing technological innovation. Technovation 1998; 18(1): 13–23.

    Article  Google Scholar 

  54. Howells J. Going global: the use of ICT networks in research and development. Res Policy 1995; 24: 169–84.

    Article  Google Scholar 

  55. D’Emanuele A. The Internet: a tool for delivering and exchanging information. Int Pharm J 1998; 10: 129–34.

    Google Scholar 

  56. D’Emanuele A. Pharmweb: pharmaceutical information on the internet. Pharm Sci Technol Today 1998; 1: 2–4.

    Article  Google Scholar 

  57. D’Emanuele A. The Internet. Pharm J 1998; 260: 26–8.

    Google Scholar 

  58. D’Emanuele A. Pharmweb: pharmaceutical information on the Internet. In: Bakker S, editor. Health information management: what strategies. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1997: 219–23.

    Google Scholar 

  59. D’Emanuele A. The Internet: a global communication tool. Int Pharm J 1995; 9(2): 68–72.

    Google Scholar 

  60. Appleby C. E-health & pharmaceuticals. Health Forum J 2001 Jan–Feb; 44(1): 17–21.

    PubMed  CAS  Google Scholar 

  61. World Health Organization. The UMC — the global intelligence network for benefits and risks in medicinal products. Available from URL: http://www.whoumc.org/home/html [Accessed 2002 Sep 6].

  62. European Union. International Conference on Harmonisation. Available from URL: http://www.ich.org [Accessed 2002 Sep 6].

  63. D’Emanuele A. How secure is the Internet? PharmWeb: news from the Internet 1997 May/Jun; 11(3). Available from URL: http://www.pharmweb.net/pwmirror/pwf/pharmwebf35.html [Accessed 2002 Oct 3].

  64. D’Emanuele A. Is someone watching you? PharmWeb: news from the Internet 1997 Sep/Oct; 11(5). Available from URL: http://www.pharmweb.net/pwmirror/pwf/pharmwebf37.html [Accessed 2002 Oct 3].

  65. California HealthCare Foundation. Privacy: report on the privacy policies and practices of health web sites. Oakland (CA): California HealthCare Foundation, 2000 Jan.

  66. European Commission. Information Society Website. Available from URL: htttp://europa.eu.int/ISPO/legal/en/dataprot/dataprot.html [Accessed 2002 Oct 3].

  67. European Union. International Conference on Harmonisation. E2B clinical safety data management: data elements for transmission of individual case safety. Available from URL: http://www.ich.org/lbis.html [Accessed 2002 Sep 6].

  68. European Union. International Conference on Harmonisation. M2 Multidisciplinary Group 2: electronic standards for the transfer of regulatory information. Available from URL: http://www.ich.org/ich5.html [Accessed 2002 Sep 6].

  69. European Union. International Conference on Harmonisation. Ml International medical terminology/Medical dictionary for regulatory activities. Available from URL: http://www.ich.org/ich5m.html [Accessed 2002 Oct 3].

  70. EC Council Directive 92/28/EEC concerning the advertising of medicinal products for human use. Official Journal of the European Communities, 1992, L113, 13 [online]. Available from URL: European Union Document Delivery Service http://www.eudor.eur-op.eu.int [Accessed 2002 Oct 3].

  71. US Food and Drug Administration. FDA Internet guidance. The Pink Sheet 1997; 59(21): 7.

    Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this manuscript. The author has no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Department of Family Medicine, Maastricht University, PO Box 616, Maastricht, 6200 MD, The Netherlands

    François M. H. M. Dupuits (Researcher, Lecturer)

Authors
  1. François M. H. M. Dupuits
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to François M. H. M. Dupuits.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dupuits, F.M.H.M. The Effects of the Internet on Pharmaceutical Consumers and Providers. Dis-Manage-Health-Outcomes 10, 679–691 (2002). https://doi.org/10.2165/00115677-200210110-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200210110-00002

Keywords

Search

Navigation